Dr. Joseph G. Pressey
Claim this profileCincinnati Children's Hospital Medical Center
Studies Cancer
Studies Solid Tumors
22 reported clinical trials
70 drugs studied
Area of expertise
1Cancer
Stage IV
FOXO1 fusion negative
FOXO1 fusion positive
2Solid Tumors
Stage IV
APC negative
FBXW7 negative
Affiliated Hospitals
Clinical Trials Joseph G. Pressey is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Tegavivint
for Recurrent or Refractory Cancer
This phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come back (recurrent) or does not respond to treatment (refractory). Tegavivint interferes with the binding of beta-catenin to TBL1, which may help stop the growth of tumor cells by blocking the signals passed from one molecule to another inside a cell that tell a cell to grow.
Recruiting1 award Phase 1 & 215 criteria
More about Joseph G. Pressey
Clinical Trial Related10 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Joseph G. Pressey has experience with
- Cyclophosphamide
- Dactinomycin
- Larotrectinib
- Ipatasertib
- Binimetinib
- Vincristine
Breakdown of trials Joseph G. Pressey has run
Cancer
Solid Tumors
Brain Tumor
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph G. Pressey specialize in?
Joseph G. Pressey focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are FOXO1 fusion negative.
Is Joseph G. Pressey currently recruiting for clinical trials?
Yes, Joseph G. Pressey is currently recruiting for 7 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Joseph G. Pressey has studied deeply?
Yes, Joseph G. Pressey has studied treatments such as Cyclophosphamide, Dactinomycin, Larotrectinib.
What is the best way to schedule an appointment with Joseph G. Pressey?
Apply for one of the trials that Joseph G. Pressey is conducting.
What is the office address of Joseph G. Pressey?
The office of Joseph G. Pressey is located at: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229 United States. This is the address for their practice at the Cincinnati Children's Hospital Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.